- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Clinical trial condition
Recurrent Hodgkin Lymphoma
Explore clinical trials studying Recurrent Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
28 public trials
4 recruiting studies
Recurrent Hodgkin Lymphoma trial results
NCT04681105
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT03739619
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Completed
Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT02744612
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- NYP/Weill Cornell Medical Center New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT02824029
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
- Locations
-
- University of Michigan Health System Ann Arbor, Michigan, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- University of Tennessee Knoxville, Tennessee, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT03013933
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
NCT02869633
- Conditions
- Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT02304458
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
NCT03096782
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02960646
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +57 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States